Secondary diagnostic testing for myasthenia gravis when first-line diagnostic tests are negative. Screen for presence of thymoma in patients with myasthenia gravis.
Semi-Quantitative Enzyme-Linked Immunosorbent Assay
This test is New York DOH approved.
Effective January 17, 2012
||0.72 IV or greater
In patients with early-onset myasthenia gravis with anti-acetylcholine receptor antibodies, the presence of titin antibody indicates a 95-100 percent likelihood of an underlying thymoma
See Compliance Statement D: www.aruplab.com/CS